ARCA
A critical step in mRNA processing is the addition of a 5’ cap structure, a 5'-5' triphosphate linkage between the 5' initiating terminal of the RNA and a guanosine nucleotide. The cap is then methylated enzymatically at the N-7 position of the guanosine to form a mature mCAP.
And now, Anti Reverse Cap Analog (ARCA) is introduced. ARCA with the ability only inserting in the proper orientation, results in forming mRNAs that can be translated twice efficiently as those initiated with mCAP.
When preparing synthetic mRNA, the cap is often added prior to use in order to stabilize the mRNA and significantly enhance translation. Using a 4:1 mixture of a cap analog to GTP in transcription reactions will cap 80% of the resulting mRNAs.
References:
[1]. Ramanathan A1, Robb GB1, et al, mRNA capping: biological functions and applications. Nucleic Acids Res. 2016 Sep 19;44(16):7511-26.
[2]. Guo XR1,2, Wang XL2, et al, PDX-1 mRNA-induced reprogramming of mouse pancreas-derived mesenchymal stem cells into insulin-producing cells in vitro. Clin Exp Med. 2015 Nov;15(4):501-9.
[3]. Lee K1, Yu P2,et al, Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells. Int J Nanomedicine. 2015 Mar 6;10:1841-54.
[4]. Kenney SP1, Meng XJ2. The lysine residues within the human ribosomal protein S17 sequence naturally inserted into the viral nonstructural protein of a unique strain of hepatitis E virus are important for enhanced virus replication. J Virol. 2015 Apr;89(7):3793-803.
[5]. Almåsbak H1, Walseng E2,et al, Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model. Gene Ther. 2015 May;22(5):391-403.
- 1. Peiying Li, et al. "Targeted mRNA Nanoparticles Ameliorate Blood–Brain Barrier Disruption Postischemic Stroke by Modulating Microglia Polarization." ACS Nano. 2024 Jan 30;18(4):3260-3275. PMID: 38227975
- 2. Derin Sevenle, Mehmet Toner, et al. "High throughput intracellular delivery by viscoelastic mechanoporation." Nat Commun. 2024 Jan 2;15:115. PMID: 38167490
- 3. Jian Xu, Rui Wang, et al. "Oligodendrocyte progenitor cell-specific delivery of lipid nanoparticles loaded with Olig2 synthetically modified messenger RNA for ischemic stroke therapy." Acta Biomater. 2024 Jan 15:174:297-313. PMID: 38096960
- 4. Mingzhu Gao, Maoping Tang, et al. "Modulating Plaque Inflammation via Targeted mRNA Nanoparticles for the Treatment of Atherosclerosis." ACS Nano. 2023 Sep 26;17(18):17721-17739. PMID: 37669404
- 5. Jian Xu, Zhihua Yang, et al. "Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA." Commun Biol. 2022 Oct 14;5(1):1095. PMID: 36241911
- 6. Jingjing Zhang, Yun Li, et al. "Genome-wide CRISPR/Cas9 library screen identifes PCMT1 as a critical driver of ovarian cancer metastasis." J Exp Clin Cancer Res. PMID: 35033172
Physical Appearance | Solution |
Storage | Store at -20°C or below |
M.Wt | 817.4 (free acid) |
Formula | C22H32N10O18P3 (free acid) |
Synonyms | Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G |
SDF | Download SDF |
Canonical SMILES | OC1C(COP([O-])(OP([O-])(OP([O-])(OCC2OC(N3C=[N+](C)C4=C3N=C(N)NC4=O)C(O)C2OC)=O)=O)=O)OC(N5C=NC6=C5N=C(N)NC6=O)C1O |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
-
Purity = ≥95% by AX-HPLC
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
Chemical structure
